Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Durr, A.

Refine Results

Resource Type

Availability

Creation Date

Show more

Author

Show more

Language

Search results

  • RSS Feed
(41 - 60 of 63)

Pages

ASSOCIATION BETWEEN BRAIN VOLUME AND WHITE MATTER MICROSTRUCTURE IN HEALTHY CONTROLS
Correction of inter-scanner and within-subject variance in structural MRI based automated diagnosing
CAN THE DISTRIBUTION OF CAUDATE ATROPHY RATES SEEN OVER SHORT TIME INTERVALS BE PREDICTED FROM CHANGES OVER LONGER INTERVALS?
DIFFUSION TENSOR IMAGING AND NEUROPSYCHIATRIC DISTURBANCE IN HUNTINGTON'S DISEASE
6-, 9-AND 15-MONTH CHANGE IN CORTICAL THICKNESS AND REGION-OF-INTEREST VOLUME AND DIFFUSION METRICS IN HUNTINGTON'S DISEASE: INFORMING TRIAL DESIGN
The neuroanatomy of subthreshold depressive symptoms in Huntington's disease: a combined diffusion tensor imaging (DTI) and voxel-based morphometry (VBM) study
The structural correlates of functional deficits in early huntington's disease
Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data
8OHdG is not a biomarker for Huntington disease state or progression
Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy
OCULOMOTOR DEFICITS IN PREMANIFEST AND EARLY HUNTINGTON'S DISEASE AND THEIR STRUCTURAL BRAIN CORRELATES: THE LONGITUDINAL TRACK-HD STUDY
CORPUS CALLOSAL ATROPHY IN HUNTINGTON'S DISEASE
A MULTICENTRE APPROACH FOR THE DETECTION OF PATTERNS OF IMPAIRMENT IN HUNTINGTON'S DISEASE BY USING DIFFUSION TENSOR IMAGING
EVALUATION OF MULTI-MODAL, MULTI-SITE IMAGING MEASURES IN HUNTINGTON'S DISEASE: BASELINE RESULTS FROM THE PADDINGTON STUDY
THE NEUROANATOMY OF DEPRESSION: EVIDENCE FROM HUNTINGTON'S DISEASE
8OHDG IS NOT A BIOMARKER FOR HUNTINGTON'S DISEASE; LESSONS FOR FUTURE BIOMARKER STUDIES
THE POTENTIAL OF A COMPOSITE COGNITIVE SCORE FOR TRACKING PROGRESSION IN HUNTINGTON'S DISEASE
Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease
Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data
A Two-Stage Meta-Analysis Identifies Several New Loci for Parkinson's Disease

Pages